Uncertainty follows court's rejection of Purdue opioids deal
A federal judgeโs decision to reject a multibillion dollar opioid settlement involving OxyContin maker Purdue Pharma is being hailed as a step toward justice by advocates who have long called for greater accountability for the family that owns the company.
OxyContin maker Purdue Pharma to plead to 3 criminal charges as part of settlement of more than $8B
WASHINGTON โ Purdue Pharma, the company that makes OxyContin, the powerful prescription painkiller that experts say helped touch off an opioid epidemic, will plead guilty to three federal criminal charges as part of a settlement of more than $8 billion, Justice Department officials announced Wednesday. To Massachusetts Attorney General Maura Healey, the Justice Department โfailedโ and she said in a statement that she was not done with either Purdue or the Sacklers. Purdue will make a direct payment to the government of $225 million, which is part of a larger $2 billion criminal forfeiture. About half the states oppose that settlement, and also wrote Barr to ask him not to make the federal deal that includes converting Purdue into a public benefit corporation. As the maker of the best-known prescription opioid, Purdue is the highest-profile player in the opioid crisis, but itโs far from the other one.